SunTrust analyst James Sheehan tells investors in a research note that he expects chemical companies to report in-line to below-consensus Q3 results driven by the trade war, slowing GDP in Europe, weak automotive and manufacturing end markets, loosening supply/demand for certain commodity product chains and FX headwinds. Looking ahead, the analyst sees "cautious" commentary for Q4 given the lack of end market acceleration and continued USD strength. The analyst lowered his price target for Chemours (CC) to $16 from $14, for Dow Inc (DOW) to $46 from $52, for Corteva (CTVA) to $28 from $30, for DuPont (DD) to $68 from $75, for Eastman Chemical (EMN) to $75 from $80, for Element Solutions (ESI) to $10 from $11, for Kraton (KRA) to $24 from $33 and for Kronos Worldwide (KRO) to $12 from $13. Sheehan raised his price target for Celanese (CE) to $120 from $108.

JPMorgan analyst Jeffrey Zekauskas upgraded Dow Inc. to Overweight from Neutral with a price target of $61, up from $55. The analyst says Dow is capable of outperforming because it is a beneficiary of higher oil prices, it has a "durable" 5% dividend yield, its value is sensitive to acceleration in global economic activity, and its downside risk is "cushioned by the existence of global political tensions." Dow benefits from a higher oil price because its raw materials slate is largely low-cost natural gas liquids, the analyst tells investors in a research note.

JPMorgan upgraded Dow Inc. to Overweight from Neutral with a $61 price target.

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.  1... To see the rest of the story go to thefly.com. See Story Here

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.  1... To see the rest of the story go to thefly.com. See Story Here